ArticleJournal of thoracic disease2026

The efficacy and predictive factors of first-line immune checkpoint inhibitors for advanced non-small cell lung cancer with driver or non-driver gene alterations: a retrospective cohort study.

Qi He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.